90 related articles for article (PubMed ID: 19893993)
1. Oral rapamycin attenuates atherosclerosis without affecting the arterial responsiveness of resistance vessels in apolipoprotein E-deficient mice.
Gadioli AL; Nogueira BV; Arruda RM; Pereira RB; Meyrelles SS; Arruda JA; Vasquez EC
Braz J Med Biol Res; 2009 Dec; 42(12):1191-5. PubMed ID: 19893993
[TBL] [Abstract][Full Text] [Related]
2. Endothelial dysfunction of resistance vessels in female apolipoprotein E-deficient mice.
Cola MS; Gava AL; Meyrelles SS; Vasquez EC
Lipids Health Dis; 2010 May; 9():51. PubMed ID: 20482882
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of vascular function in apolipoprotein E knockout mice with angiotensin-dependent renovascular hypertension.
Arruda RM; Peotta VA; Meyrelles SS; Vasquez EC
Hypertension; 2005 Oct; 46(4):932-6. PubMed ID: 16087779
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice: inhibitory effect on monocyte chemotaxis.
Pakala R; Stabile E; Jang GJ; Clavijo L; Waksman R
J Cardiovasc Pharmacol; 2005 Oct; 46(4):481-6. PubMed ID: 16160601
[TBL] [Abstract][Full Text] [Related]
5. Effect of sirolimus on the cholesterol content of aortic arch in ApoE knockout mice.
Basso MD; Nambi P; Adelman SJ
Transplant Proc; 2003 Dec; 35(8):3136-8. PubMed ID: 14697997
[TBL] [Abstract][Full Text] [Related]
6. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of the immunosuppressant sirolimus against aortic atherosclerosis in apo E-deficient mice.
Elloso MM; Azrolan N; Sehgal SN; Hsu PL; Phiel KL; Kopec CA; Basso MD; Adelman SJ
Am J Transplant; 2003 May; 3(5):562-9. PubMed ID: 12752312
[TBL] [Abstract][Full Text] [Related]
8. Oral rapamycin inhibits growth of atherosclerotic plaque in apoE knock-out mice.
Waksman R; Pakala R; Burnett MS; Gulick CP; Leborgne L; Fournadjiev J; Wolfram R; Hellinga D
Cardiovasc Radiat Med; 2003; 4(1):34-8. PubMed ID: 12892771
[TBL] [Abstract][Full Text] [Related]
9. Standardized fraction of Xylocarpus moluccensis fruits improve vascular relaxation and plaque stability in dyslipidemic models of atherosclerosis.
Kanshana JS; Rebello SC; Pathak P; Kanuri BN; Aggarwal H; Srivastava V; Khanna V; Singh V; Jagavelu K; Barthwal MK; Dikshit M
J Ethnopharmacol; 2018 Mar; 213():81-91. PubMed ID: 29129602
[TBL] [Abstract][Full Text] [Related]
10. Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE
Song Y; Huang Z; Liu X; Pang Z; Chen J; Yang H; Zhang N; Cao Z; Liu M; Cao J; Li C; Yang X; Gong H; Qian J; Ge J
Nanomedicine; 2019 Jan; 15(1):13-24. PubMed ID: 30171903
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139
[TBL] [Abstract][Full Text] [Related]
12. Chronic Cadmium Exposure Accelerates the Development of Atherosclerosis and Induces Vascular Dysfunction in the Aorta of ApoE
Oliveira TF; Batista PR; Leal MA; Campagnaro BP; Nogueira BV; Vassallo DV; Meyrelles SS; Padilha AS
Biol Trace Elem Res; 2019 Jan; 187(1):163-171. PubMed ID: 29707746
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin modulates the eNOS vs. shear stress relationship.
Cheng C; Tempel D; Oostlander A; Helderman F; Gijsen F; Wentzel J; van Haperen R; Haitsma DB; Serruys PW; van der Steen AF; de Crom R; Krams R
Cardiovasc Res; 2008 Apr; 78(1):123-9. PubMed ID: 18079107
[TBL] [Abstract][Full Text] [Related]
14. Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine.
Ramzy D; Rao V; Tumiati LC; Xu N; Miriuka S; Delgado D; Ross HJ
Circulation; 2006 Jul; 114(1 Suppl):I214-9. PubMed ID: 16820575
[TBL] [Abstract][Full Text] [Related]
15. Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.
Tesanovic S; Vinh A; Gaspari TA; Casley D; Widdop RE
Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1606-13. PubMed ID: 20448208
[TBL] [Abstract][Full Text] [Related]
16. Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice.
Baumhäkel M; Custodis F; Schlimmer N; Laufs U; Böhm M
Atherosclerosis; 2010 Sep; 212(1):55-62. PubMed ID: 20347444
[TBL] [Abstract][Full Text] [Related]
17. Low dose dietary nitrate improves endothelial dysfunction and plaque stability in the ApoE
Bakker JR; Bondonno NP; Gaspari TA; Kemp-Harper BK; McCashney AJ; Hodgson JM; Croft KD; Ward NC
Free Radic Biol Med; 2016 Oct; 99():189-198. PubMed ID: 27519268
[TBL] [Abstract][Full Text] [Related]
18. Effect of tempol on altered angiotensin II and acetylcholine-mediated vascular responses in thoracic aorta isolated from rats with insulin resistance.
Viswanad B; Srinivasan K; Kaul CL; Ramarao P
Pharmacol Res; 2006 Mar; 53(3):209-15. PubMed ID: 16412660
[TBL] [Abstract][Full Text] [Related]
19. Impact of stenting and oral sirolimus on endothelium-dependent and independent coronary vasomotion.
Fernandes RW; Dantas JM; Oliveira DC; Bezerra HG; Brito FS; Lima VC
Arq Bras Cardiol; 2012 Apr; 98(4):290-8. PubMed ID: 22406990
[TBL] [Abstract][Full Text] [Related]
20. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
